NADPH cytochrome P450 reductase

Publikacje

• Artykuł Bioreductive activation of antitumour drugs, doxorubicin and pirarubicin, does not affect their ability to induce apoptosis of sensitive and multidrug resistant leukaemia HL60 cells / Kostrzewa-Nowak Dorota, Jolanta Tarasiuk. // Anticancer Research. 2021, vol. 41 iss. 3, s.1429-1438 DOI: 10.21873/anticanres.14900 2021
• Artykuł DNA damage induced by NADPH cytochrome P450 reductase-activated idarubicin in sensitive and multidrug resistant MCF7 breast cancer cells / Wojciech Żwierełło, Agnieszka Maruszewska, Robert Nowak, Dorota Kostrzewa-Nowak, Jolanta Tarasiuk. // Pharmacological Reports. 2017, vol. 69 iss. 1, s.185-195 DOI: 10.1016/j.pharep.2016.10.002 2017
• Artykuł DNA damage induced by NADPH cytochrome P450 reductase-activated idarubicin in sensitive and multidrug resistant Mcf7 breast cancer cells / Wojciech Żwierełło, Agnieszka Maruszewska, Robert Nowak, Dorota Kostrzewa-Nowak, Jolanta Tarasiuk. // Tumor Biology : Tumor Markers, Tumor Targeting and Translational Cancer Research. 2015, vol. 36 suplement 1, s.87-88 2015
• Artykuł Effect of reductive activation of antitumour anthracycline drugs by NADPH cytochrome P450 reductase on their intracellular accumulation in sensitive LoVo and multidrug resistant LoVo/DX colon cancer cells / Robert Nowak, Wojciech Żwierełło, Dorota Kostrzewa-Nowak, Jolanta Tarasiuk. // Anticancer Research. 2014, vol. 34 no. 10, s.6200-6201 2014

Lista słów kluczowych